| Closed |
SWOG-8926 |
Evaluation of Low Dose Continuous Infusion 5-Fluorouracil in Patients with Advanced and Recurrent Renal Cell Carcinoma |
10/1/1989 |
2/15/1991 |
100% |
|
Published
|
| Closed |
SWOG-7970 |
Evaluation of m-AMSA in Acute Leukemia |
10/11/1979 |
5/11/1982 |
|
|
|
| Closed |
SWOG-7937 |
Evaluation of m-AMSA in Metastatic Carcinoma of the GU Tract Except Renal Carcinoma |
11/20/1979 |
9/10/1982 |
|
|
|
| Closed |
SWOG-7958 |
Evaluation of m-AMSA in Metastatic or Recurrent Epithelial Carcinomas of the Female Genital Tract |
12/14/1979 |
1/31/1983 |
|
|
|
| Closed |
SWOG-8276 |
Evaluation of m-AMSA VP-16-213 and 5-Azacytidine Combination Chemotherapy in Adult Acute Non-Lymphocytic Leukemia |
|
1/11/1985 |
|
|
Published
|
| Closed |
SWOG-8565 |
Evaluation of Menogaril (NSC-269148) in Colorectal Carcinoma |
8/1/1986 |
3/1/1988 |
|
|
Published
|
| Closed |
SWOG-8567 |
Evaluation of Menogaril (NSC-269148) in Non-Small Cell Lung Carcinoma |
1/3/1986 |
8/1/1987 |
|
|
Published
|
| Closed |
SWOG-8513 |
Evaluation of Menogaril (NSC-269148) in Pancreatic Adenocarcinoma |
1/3/1986 |
2/15/1987 |
|
|
Published
|
| Closed |
SWOG-8504 |
Evaluation of Menogaril (NSC-269148) in Renal Cell Carcinoma |
9/27/1985 |
1/15/1987 |
|
|
Published
|
| Closed |
SWOG-8509 |
Evaluation of Menogaril in Adenocarcinoma of the Prostate |
9/27/1985 |
9/1/1988 |
|
|
Published
|
| Closed |
SWOG-8943 |
Evaluation of Merbarone in Advanced Soft-Tissue Sarcomas |
12/15/1989 |
7/1/1991 |
100% |
|
Published
|
| Closed |
SWOG-8939 |
Evaluation of Merbarone in Colorectal Cancer |
4/15/1990 |
7/15/1991 |
23% |
|
|
| Closed |
SWOG-8906 |
Evaluation of Merbarone in Hepatoma, Phase II |
2/1/1990 |
5/1/1992 |
63% |
|
Published
|
| Closed |
SWOG-8913 |
Evaluation of Merbarone in Malignant Melanoma, Phase II |
9/1/1991 |
6/15/1993 |
100% |
|
Published
|
| Closed |
SWOG-8916 |
Evaluation of Merbarone in Pancreatic Adenocarcinoma |
3/15/1990 |
6/15/1991 |
86% |
|
Published
|
| Closed |
SWOG-8929 |
Evaluation of Merbarone in Patients with Advanced Renal Cell Carcinoma |
4/15/1990 |
8/1/1992 |
100% |
|
Published
|
| Closed |
SWOG-7860 |
Evaluation of MGBG (methyl-Glyoxal Bis-Guanylhydrazone; Methyl GAG) in Solid Tumors and Refractory Hematologic Malignancies. Closed to GU, GI and Breast: 5/80 |
1/18/1978 |
1/31/1983 |
|
|
|
| Closed |
SWOG-7940/41 |
Evaluation of MGBG in Metastatic Adenocarcinoma of the Large Bowel |
2/27/1980 |
9/23/1980 |
|
|
|
| Closed |
SWOG-7959 |
Evaluation of MGBG in Metastatic Renal Carcinoma |
12/14/1979 |
12/3/1980 |
|
|
|
| Closed |
SWOG-8042 |
Evaluation of MGBG in Pancreatic Adenocarcinoma |
1/28/1981 |
5/5/1982 |
|
|
Published
|
